Importantly, the ‘virus-washing’ methodology provided the key experimental data for the conclusion that IFNβ-ACE2 mechanistically targeted IFN-β to confer high anti-viral efficacy to the exact physical interface of infection. The gene discussed is IFNB1; the disease is infection.